No Data
No Data
Guangzhou Baiyunshan Pharma Gets Local Approval to Reduce, Add Production Lines
Baiyunshan Pharma's Venture Capital Fund Completes Registration
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (HKG:874) Largest Shareholders Are Private Companies With 46% Ownership, Individual Investors Own 35%
Express News | Guangzhou Baiyunshan Pharmaceutical - Proposes to Appoint Li Xiaojun as an Executive Director of 9TH Session
Baiyunshan Unit Gets Authorization for Indian Gooseberry Lozenge Production
Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) May Have Issues Allocating Its Capital
No Data